Compare TSEM & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSEM | FMS |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | Israel | Germany |
| Employees | N/A | N/A |
| Industry | Semiconductors | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 14.2B |
| IPO Year | 1996 | N/A |
| Metric | TSEM | FMS |
|---|---|---|
| Price | $190.00 | $22.45 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | ★ $161.75 | $30.00 |
| AVG Volume (30 Days) | ★ 3.6M | 419.0K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.51 | $0.45 |
| Revenue Next Year | $28.99 | $3.76 |
| P/E Ratio | $66.16 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.02 | $20.96 |
| 52 Week High | $198.94 | $30.46 |
| Indicator | TSEM | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 65.18 | 47.22 |
| Support Level | $111.97 | $21.56 |
| Resistance Level | $195.36 | $24.08 |
| Average True Range (ATR) | 15.52 | 0.35 |
| MACD | 3.08 | 0.05 |
| Stochastic Oscillator | 81.04 | 49.75 |
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.